ArticleMediterranean journal of hematology and infectious diseases2018

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition.

Emmanouil Spanoudakis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.